华绿生物
(300970)
| 流通市值：14.29亿 | | | 总市值：14.31亿 |
| 流通股本：1.18亿 | | | 总股本：1.18亿 |
| 报告期 | 2024-03-31 | 2023-12-31 | 2023-09-30 | 2023-06-30 |
| 公司类型 | 通用 | 通用 | 通用 | 通用 |
| 一、营业总收入 | 256,905,255.97 | 996,221,375.81 | 750,999,036.22 | 528,277,665.57 |
| 营业收入 | 256,905,255.97 | 996,221,375.81 | 750,999,036.22 | 528,277,665.57 |
| 二、营业总成本 | 257,780,429.22 | 959,058,269.35 | 675,263,870.84 | 421,675,138.73 |
| 营业成本 | 236,078,230.42 | 861,515,565.81 | 607,781,864.66 | 385,988,989.6 |
| 税金及附加 | 140,975.8 | 553,097.67 | 458,947.86 | 263,376.89 |
| 销售费用 | 2,981,054.76 | 9,496,818.47 | 7,083,830.72 | 4,198,065.11 |
| 管理费用 | 17,671,183.25 | 70,827,874.62 | 48,949,733.93 | 23,648,534.47 |
| 研发费用 | 1,857,734.25 | 16,528,200.57 | 13,177,331.95 | 8,329,018.9 |
| 财务费用 | -948,749.26 | 136,712.21 | -2,187,838.28 | -752,846.24 |
| 其中:利息费用 | - | 8,746,869.77 | 4,806,184.58 | 6,971,694.29 |
| 其中:利息收入 | - | 8,636,168.21 | -7,171,947.39 | 4,138,326.03 |
| 加:公允价值变动收益 | - | -173,780.82 | -173,780.82 | -173,780.82 |
| 加:投资收益 | - | 540,243.73 | 540,243.73 | 540,243.73 |
| 资产处置收益 | -16,844.24 | -10,893,647.2 | -6,790,660.88 | -4,685,681.11 |
| 资产减值损失(新) | 32,648.7 | -8,336,377.16 | -1,988,835.17 | -132,149.36 |
| 信用减值损失(新) | -4,773.07 | -2,356,056.55 | 227,526.59 | 143,455.14 |
| 其他收益 | 3,096,846.97 | 11,221,433.97 | 7,136,597.45 | 4,774,897.51 |
| 营业利润平衡项目 | 0 | 0 | 0 | 0 |
| 四、营业利润 | 2,232,705.11 | 27,164,922.43 | 74,686,256.28 | 107,069,511.93 |
| 加:营业外收入 | 254,141.36 | 211,404.96 | 9,434.56 | 9,434.56 |
| 减:营业外支出 | 59,579.45 | 1,007,905.81 | 575,602.68 | 321,261.02 |
| 利润总额平衡项目 | 0 | 0 | 0 | 0 |
| 五、利润总额 | 2,427,267.02 | 26,368,421.58 | 74,120,088.16 | 106,757,685.47 |
| 减:所得税费用 | 61.06 | 1.78 | - | - |
| 六、净利润 | 2,427,205.96 | 26,368,419.8 | 74,120,088.16 | 106,757,685.47 |
| 持续经营净利润 | - | 26,368,419.8 | 74,120,088.16 | 106,757,685.47 |
| 归属于母公司股东的净利润 | 1,739,546.28 | 30,348,940.26 | 75,764,508.43 | 107,129,167.19 |
| 少数股东损益 | 687,659.68 | -3,980,520.46 | -1,644,420.27 | -371,481.72 |
| (一)基本每股收益 | 0.02 | 0.26 | 0.65 | 0.91 |
| (二)稀释每股收益 | 0.02 | 0.26 | 0.65 | 0.91 |
| 九、综合收益总额 | 2,427,205.96 | 26,368,419.8 | 74,120,088.16 | 106,757,685.47 |
| 归属于母公司股东的综合收益总额 | 1,739,546.28 | 30,348,940.26 | 75,764,508.43 | 107,129,167.19 |
| 归属于少数股东的综合收益总额 | 687,659.68 | -3,980,520.46 | -1,644,420.27 | -371,481.72 |
| 公告日期 | 2024-04-23 | 2024-04-23 | 2023-10-27 | 2023-08-19 |
| 审计意见(境内) | | 标准无保留意见 | | |